For most healthy adults, daily supplements are not necessary and, in several well-documented cases, cause harm. The evidence supports targeted use in defined groups: folic acid before and during early pregnancy, vitamin D in people with documented deficiency, B12 for vegans and adults over 50, and iron or iodine where deficiency is confirmed by testing. For everyone else, a multivitamin delivers a small and inconsistent benefit at best. The largest randomized trials show no reduction in death from cardiovascular disease or cancer among general-population users, while high-dose single nutrients such as beta-carotene and vitamin E have increased mortality in trials. In short: supplements are medicine-like interventions, not dietary insurance, and they belong to specific people for specific reasons.
How supplements work inside the body: absorption, transport, and saturation
A supplement is not food plus convenience. It is a chemical dose delivered without the matrix of fiber, fat, protein, and phytochemicals that food provides, and that difference changes absorption.
Fat-soluble vitamins (A, D, E, K) need dietary fat to be absorbed efficiently. Taken on an empty stomach, vitamin D absorption can fall well below the 50 percent seen with a fat-containing meal. Water-soluble vitamins (C and the B complex) are absorbed through transporter proteins that saturate. Once those transporters are full, excess is excreted in urine.
In plain terms: your gut has a limited number of doors for each nutrient, and a megadose mostly knocks on closed doors.
This saturation threshold explains why high-dose vitamin C (1,000 mg or more) produces only marginally higher blood levels than 200 mg. It also explains why the same dose produces different blood levels in different people, a variability of two- to threefold for many nutrients that the supplement label never shows.
Minerals compete. Calcium, iron, zinc, and magnesium share absorption pathways, so a single pill packing all four at high doses delivers less of each than separate doses taken hours apart. This is one mechanistic reason multivitamins underperform single-nutrient trials.
Quantified context: what the large trials actually found
The strongest evidence comes from randomized controlled trials and their meta-analyses. The numbers are sobering for the general-population claim.
The U.S. Preventive Services Task Force, in its 2022 recommendation statement, concluded there is insufficient evidence that multivitamins reduce cardiovascular disease or cancer mortality in healthy adults, and recommended against beta-carotene supplementation for lung cancer prevention. In the same statement, vitamin E was recommended against for cancer and cardiovascular prevention because trials showed no benefit and possible harm.
The numbers behind that: in the ATBC trial of male smokers, beta-carotene supplementation raised lung cancer incidence by roughly 18 percent and total mortality by about 8 percent over 5 to 8 years. In the CARET trial of asbestos-exposed workers and smokers, the beta-carotene plus retinol arm was stopped early after a 28 percent increase in lung cancer deaths.
Vitamin E tells a parallel story. A 2005 meta-analysis by Miller and colleagues covering 19 trials and over 135,000 participants found that high-dose vitamin E (400 IU per day or more) was associated with a 4 to 6 percent increase in all-cause mortality. At the standard 15 mg (22 IU) dietary level, no such signal appears.
Where supplements do show measurable benefit, the effect is concentrated. The 2017 USPSTF folic acid recommendation found that 400 to 800 micrograms daily, started at least one month before conception, reduces neural tube defects by 50 to 70 percent. Vitamin D plus calcium reduces fracture risk in institutionalized older adults by roughly 20 percent but shows little benefit in community-dwelling adults with adequate levels.
Who actually benefits: the evidence-backed indications
Supplement use is not uniformly good or bad. It is a question of population. The groups with the strongest trial support share one feature: a documented or highly probable deficiency.
| Group | Supplement | Dose and evidence | Trial effect |
|---|---|---|---|
| Women planning pregnancy | Folic acid | 400-800 mcg daily, start 1 month pre-conception | 50-70% fewer neural tube defects |
| Adults 50+ | Vitamin B12 | 2.4 mcg daily or fortified foods | Corrects age-related absorption decline |
| Vegans and strict vegetarians | B12 | 2.4 mcg daily or 25-100 mcg weekly | Prevents deficiency in 100% of non-supplementers over time |
| Adults with low sun exposure or dark skin | Vitamin D | 600-800 IU daily | Raises 25(OH)D above the 20 ng/mL threshold |
| Pregnant women | Iron | 27 mg daily | Reduces maternal anemia and low birth weight |
| People with diagnosed deficiency | Iron, B12, D, or others | Per lab result | Restores normal levels |
The pattern is consistent: benefit appears when intake falls below requirement and disappears when it does not. A person already meeting the Recommended Dietary Allowance through food gains nothing from topping up. This is why the same pill that prevents birth defects in one woman does nothing measurable in another.
Timing and the time course of supplementation effects
Supplements do not work on a fixed schedule; each nutrient follows its own timeline. The following table summarizes typical time-to-effect and washout for the most common supplements.
| Supplement | Time to meaningful blood change | Time to clinical effect | Washout after stopping |
|---|---|---|---|
| Folic acid | 2-4 weeks | Neural tube protection requires 1 month pre-conception | Falls over 4-8 weeks |
| Vitamin D3 | 8-12 weeks | Fracture reduction over 6-24 months | Half-life about 2-3 weeks |
| Vitamin B12 | 2-3 months (oral) | Neurologic improvement 3-12 months; irreversible after 12 | Gradual over months |
| Iron (oral) | 2-4 weeks for hemoglobin | 3-6 months to replete stores | Stores decline over 3-6 months |
| Omega-3 (EPA/DHA) | 4-8 weeks | Triglyceride reduction at 3-4 months | Returns to baseline in 4-8 weeks |
| Multivitamin | Minimal change if diet adequate | None demonstrated for mortality | Not applicable |
The vitamin B12 row carries a warning the others do not. B12 deficiency damages the spinal cord through subacute combined degeneration, and that damage becomes irreversible after roughly 12 months of untreated deficiency. Timing matters more for B12 than for any other common supplement, which is why vegans are advised to supplement from day one rather than wait for symptoms.
The misconceptions: "natural," "megadose," and "more is safer"
Three beliefs drive most inappropriate supplement use, and each collides with the mechanism.
First, natural does not mean safe or better absorbed. The synthetic form of folic acid is actually better absorbed than the folate in food, at about 85 percent versus 50 percent. Conversely, "natural" vitamin E from some sources is less bioavailable than the synthetic form. The label word carries no pharmacological meaning.
Second, megadoses rarely deliver proportional benefit because of the saturation threshold described above. They do deliver proportional risk. Vitamin A above 3,000 IU per day in adults is linked to liver damage and bone loss; vitamin D above 4,000 IU per day raises the risk of hypercalcemia and kidney stones; selenium above 400 micrograms per day is associated with hair loss and, in one trial, a higher risk of type 2 diabetes.
Third, the counterintuitive edge case: a supplement taken because of a symptom can mask the diagnosis. High-dose B12 can normalize blood counts while the underlying deficiency, often pernicious anemia or a malabsorption disorder, continues to damage nerves. Iron supplements taken without testing can raise ferritin in a person with a genetic iron-overload condition (hemochromatosis), where the real need is the opposite of supplementation.
Warning signs that a supplement is causing harm include:
- Yellowing of the skin or eyes (possible liver stress from vitamin A or green tea extract)
- New kidney stones or blood in urine (excess vitamin C or D)
- Numbness or tingling in hands or feet (B6 toxicity above 100 mg per day is a known cause)
- Persistent nausea or abdominal pain after a new supplement
- Dark or tarry stools (iron, or bleeding)
- Unusual fatigue or hair loss (selenium or excess vitamin A)
What to actually do: a decision framework
The practical answer is to test before treating and to treat only what is deficient. The steps below convert the evidence into action.
- Eat first, then supplement. A food-first dietary pattern supplies the full nutrient matrix, and most adults meeting the RDA need no pill.
- Get a 25(OH)D, ferritin, and B12 level if you have symptoms or risk factors. These three tests cover the most common deficiencies and cost roughly USD 30 to 60 each.
- Take only the indicated supplement. Folic acid if planning pregnancy; B12 if vegan or over 50; D if below 20 ng/mL; iron only if ferritin is low.
- Separate competing minerals. Take calcium and iron at least 2 hours apart; take vitamin D with a fat-containing meal.
- Recheck after 8 to 12 weeks. Adjust the dose to the lab result rather than continuing indefinitely.
- Buy third-party tested products. The FDA does not approve supplements before sale, and independent testing programs verify label accuracy.
The single most useful rule is this: treat a supplement like a drug ordered after a test, not a habit started after a worry.
Limitations and open questions
The evidence base has real gaps. Most large trials lasted 5 to 15 years, which may be too short to detect cancer effects that take decades to emerge. Many trials used doses too low to change status in deficient people, or too high to reflect any reasonable diet, so results may not apply to typical users.
The literature is also contaminated by the supplement industry's influence on research funding and by publication bias toward positive findings. A 2019 analysis found that most randomized trials of supplements were either industry-funded or showed no effect, and the industry-funded subset was more likely to report benefit.
The honest summary is that the science supports targeted supplementation clearly and population-wide supplementation not at all. The next decade may refine which subgroups benefit from omega-3, vitamin D, or multivitamins, but the core finding is unlikely to reverse. Supplements are best understood as precision tools, not dietary insurance.